Cargando…
Treatment of high-risk bleeding with susoctocog alfa in a patient with acquired haemophilia A and a nosocomial severe acute respiratory syndrome coronavirus 2 infection
We report the case of a man in his early 70s with idiopathic acquired haemophilia A and persistent high-titre type II inhibitors on immunosuppressive treatment to eradicate the inhibitor. As complications, he had a nosocomial severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, wh...
Autores principales: | Fernández-Oliveira, Carla, Rotea-Salvo, Sandra, Fernández-Docampo, Marta, González-Piñeiro, Sara, Martín-Herranz, Isabel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176986/ https://www.ncbi.nlm.nih.gov/pubmed/34011555 http://dx.doi.org/10.1136/ejhpharm-2021-002805 |
Ejemplares similares
-
Surgery and Prophylaxis with Susoctocog-Alfa in Acquired Hemophilia: Case Series and Literature Review
por: Sella, Carola, et al.
Publicado: (2023) -
Analytical Performance of Different Laboratory Methods for Measuring Susoctocog-Alfa
por: Novembrino, Cristina, et al.
Publicado: (2022) -
Lonoctocog Alfa: A Review in Haemophilia A
por: Al-Salama, Zaina T., et al.
Publicado: (2017) -
Efmoroctocog Alfa: A Review in Haemophilia A
por: Frampton, James E.
Publicado: (2021) -
Eftrenonacog Alfa: A Review in Haemophilia B
por: Lamb, Yvette N., et al.
Publicado: (2023)